MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation

IF 2.5 4区 医学 Q2 HEMATOLOGY
Shi Chen , Gayathri Srinivasan , Aruna Jaiswal , Elizabeth A. Williamson , Lingxiao Li , Dominic Arris , Daohong Zhou , Mingjiang Xu , Robert Hromas
{"title":"MiR-223-3p promotes genomic stability of hematopoietic progenitors after radiation","authors":"Shi Chen ,&nbsp;Gayathri Srinivasan ,&nbsp;Aruna Jaiswal ,&nbsp;Elizabeth A. Williamson ,&nbsp;Lingxiao Li ,&nbsp;Dominic Arris ,&nbsp;Daohong Zhou ,&nbsp;Mingjiang Xu ,&nbsp;Robert Hromas","doi":"10.1016/j.exphem.2023.10.002","DOIUrl":null,"url":null,"abstract":"<div><p>When hematopoietic cells are overwhelmed with ionizing radiation (IR) DNA damage, the alternative non-homologous end-joining (aNHEJ) repair pathway is activated to repair stressed replication forks. While aNHEJ can rescue cells overwhelmed with DNA damage, it can also mediate chromosomal deletions and fusions, which can cause mis-segregation in mitosis and resultant aneuploidy. We previously reported that a hematopoietic microRNA, miR-223-3p, normally represses aNHEJ. We found that miR-223<sup>−/−</sup> mice have increased survival of hematopoietic stem and progenitor cells (HSPCs) after sublethal IR. However, this came at the cost of significantly more genomic aberrancies, with miR-223<sup>−/−</sup> hematopoietic progenitors having increased metaphase aberrancies, including chromothripsis, and increased sequence abnormalities, especially deletions, which is consistent with aNHEJ. These data imply that when an HSPC is faced with substantial DNA damage, it may trade genomic damage for its own survival by choosing the aNHEJ repair pathway, and this choice is regulated in part by miR-223-3p.</p></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"129 ","pages":"Article 104123"},"PeriodicalIF":2.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0301472X2301737X/pdfft?md5=afb05969a5e4bb740dd86dc3ec469d7c&pid=1-s2.0-S0301472X2301737X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301472X2301737X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

When hematopoietic cells are overwhelmed with ionizing radiation (IR) DNA damage, the alternative non-homologous end-joining (aNHEJ) repair pathway is activated to repair stressed replication forks. While aNHEJ can rescue cells overwhelmed with DNA damage, it can also mediate chromosomal deletions and fusions, which can cause mis-segregation in mitosis and resultant aneuploidy. We previously reported that a hematopoietic microRNA, miR-223-3p, normally represses aNHEJ. We found that miR-223−/− mice have increased survival of hematopoietic stem and progenitor cells (HSPCs) after sublethal IR. However, this came at the cost of significantly more genomic aberrancies, with miR-223−/− hematopoietic progenitors having increased metaphase aberrancies, including chromothripsis, and increased sequence abnormalities, especially deletions, which is consistent with aNHEJ. These data imply that when an HSPC is faced with substantial DNA damage, it may trade genomic damage for its own survival by choosing the aNHEJ repair pathway, and this choice is regulated in part by miR-223-3p.

MiR223-3p促进放射后造血祖细胞基因组稳定性
当造血细胞被电离辐射(IR)DNA损伤淹没时,替代性非同源末端连接(aNHEJ)修复途径被激活以修复应激复制叉。虽然aNHEJ可以拯救被DNA损伤淹没的细胞,但它也可以介导染色体缺失和融合,这可能导致有丝分裂中的错误分离,并导致非整倍体。我们之前报道了一种造血微小RNA,miR223-3p,通常抑制aNEJ。我们发现,miR223-/-小鼠在亚致死性IR后提高了造血干细胞和祖细胞(HSPC)的存活率。然而,这是以显著更多的基因组变异为代价的,miR223/-造血祖细胞具有增加的中期变异,包括染色体畸变,以及增加的序列异常,尤其是缺失,这与aNEJ一致。这些数据表明,当HSPC面临严重的DNA损伤时,它可能会通过选择aNEJ修复途径来换取基因组损伤,而这种选择在一定程度上受到miR223-3p的调节。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Experimental hematology
Experimental hematology 医学-血液学
CiteScore
5.30
自引率
0.00%
发文量
84
审稿时长
58 days
期刊介绍: Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信